Mice tumor free and protected from metastases after treatment
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
The scientists tested a 100-year-old idea called in-situ vaccination. The idea is to put something inside a tumor and disrupt the environment that suppresses the immune system, thus allowing the natural defense system to attack the malignancy.
That something–the hard coating of cowpea mosaic virus–caused no detectible side effects, which are a common problem with traditional therapies and some immunotherapies.
The team’s research is published in the journal Nature Nanotechnology.
“The cowpea virus-based nanoparticles act like a switch that turns on the immune system to recognize and fight against the tumor – as well as to remember it,” said Nicole Steinmetz, an assistant professor of biomedical engineering at Case Western Reserve, appointed by the Case Western Reserve School of Medicine.
“The particles are shockingly potent,” said Steven Fiering, professor of microbiology and immunology at Dartmouth’s Geisel School of Medicine. “They’re easy to make and don’t need to carry antigens, drugs or other immunostimmulatory agents on their surface or inside.”
The professors studied the nanoparticles with Dartmouth’s Pat Lizotte, a molecular and cellular biology PhD student; Mee Rie Sheen, a postdoctoral fellow; and Pakdee Rojanasopondist, an undergraduate student; and Case Western Reserve’s Amy Wen, a biomedical engineering PhD student.
Taking another shot
The immune system’s ability to detect and destroy abnormal cells is thought to prevent many cancers, according to the National Cancer Institute. But when tumors start to develop, they can shut down the system, allowing tumors to grow and spread.
To restart immune defenses, the scientists used the tumor itself as if it were the antigen in a vaccine–that is, the target for antibodies produced by the immune system.
The cowpea virus shell, with its infectious components removed, acts as the adjuvant–a substance that triggers and may enhance or prolong antigen-specific immune responses.
The process and results
The researchers first switched on the immune system in mice to attack B16F10 lung melanoma or skin melanoma, leaving the mice tumor-free. When the treated mice were later injected with B16F10 skin melanoma (to re-challenge the cured mice), four out of five mice were soon cancer free and one had a slow-growing tumor.
The nanoparticles proved effective against ovarian, breast and colon tumor models. Most of the tumors deteriorated from the center and collapsed. The systemic response prevented or attacked metastatic disease, which is the deadliest form of cancer.
“You get benefits against disease you don’t even know is there yet,” Fiering said.
“Because everything we do is local, the side effects are limited,” despite the strength and extent of the immune response, Fiering said. No toxicity was found.
Harsh side effects, such as fatigue, pain, flu-like symptoms and more are common with chemo and radiation therapies and with some immunostimulation drugs.
The researchers are now trying to understand how the virus shell stimulates the immune system.
“It’s not cytotoxic, there’s no RNA involved or lipopolysaccharides that may be used as adjuvants, and it’s not simply an irritant,” Steinmetz said. “We see a specific immune response.”
The Latest on: Immune response against cancer
via Google News
The Latest on:Iimmune response against cancer
- Israeli researchers at forefront of fight against breast canceron October 17, 2019 at 11:29 am
“We want to see if these women have a weakened immune response to a cancer attack ... work goes a long way toward ensuring that their efforts will have important and lasting impact in the global fight ...
- Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Canceron October 15, 2019 at 5:07 pm
Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types ...
- Sperm and egg cell ‘immune response’ protects koala DNAon October 15, 2019 at 6:19 am
“This means that some koalas are born with koala retrovirus A – known as KoRV-A – in their genome, making them more susceptible to diseases such chlamydia and cancer ... our findings show that there ...
- Drug shows promise as immune therapy for canceron October 15, 2019 at 4:39 am
The therapy is effective alone or in combination with existing cancer immunotherapies, and it appears to have lasting effects, the researchers said. The research team, led by Yale investigators Akiko ...
- Oncolysis without viruses — inducing systemic anticancer immune responses with local therapieson October 8, 2019 at 7:26 am
can promote a similar effect owing to the release of danger-associated molecular patterns that lead to the recruitment of immune cells, thus inducing a systemic response against tumour antigens that ...
- Immune Response to Isatuximab Correlates With Clinical Response in Patients With Relapsed or Refractory Multiple Myelomaon October 7, 2019 at 8:01 am
The study additionally found that the 2 patients who had both an immune response and a clinical response also had antibodies against several myeloma antigens before starting isatuximab ... attending ...
- "Goldilocks" balance holds key to awakening the body's immune response to combat brain canceron October 4, 2019 at 12:04 pm
The prize was awarded to the discovery of a drug that activates the patient's immune response against cancer cells. Treatment with this immunotherapy drug has produced impressive long-term survival in ...
- IsoPlexis' Immune Monitoring Contributions in Precision Medicine Highlighted in Comprehensive Publication, "Biomarkers for Immunotherapy of Cancer"on September 30, 2019 at 7:40 am
IsoPlexis' single cell functional biomarker methods, published here, provide a deeper understanding of functional single cell immune response to immunotherapies. IsoPlexis (www.isoplexis.com) is ...
- Molecule found in immune system can help in killing cancer cells : Studyon September 27, 2019 at 9:55 pm
Researchers have found a naturally occurring molecule and a component of the immune system that could successfully target and kill cancer cells, according to a study. The study, published in British ...
- Avoiding Crashes in the Race Against Cancer With Immunotherapyon September 27, 2019 at 8:07 am
The underlying concept of current immunotherapy is simple: Immunotherapy drugs help a person’s immune system recog- nize the cancer as an obstacle and mount a response against it. If fighting cancer ...
via Bing News